HIV/AIDS Clinical Trials Unit (CTU) COVID-19 Admin Supplement

HIV/AIDS 临床试验单位 (CTU) COVID-19 管理补充资料

• 批准号: 10166401
• 负责人: Joseph J Eron
• 金额: $ 60万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-06-01 至 2022-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10166401
• 关键词: 2019-nCoV; AIDS prevention; AIDS/HIV problem; Address; Adherence; Adult; Agriculture; Area; Back; Belgium; COVID-19; COVID-19 pandemic; Caring; Cessation of life; Childhood; China; Clinic; Clinical; Clinical Research; Clinical Trials; Clinical Trials Network; Clinical Trials Unit; Color; Communication; Communities; Contact Tracing; Containment; Coronavirus; Country; County; Data; Detection; Diagnosis; Diagnostic; Disease; Disease Outbreaks; Doctor of Philosophy; Emerging Communicable Diseases; Ensure; Equipment; Evaluation; Farming environment; Finland; General Population; Geography; Germany; Goals; HIV; HIV Infections; Health; Healthcare; Home environment; Hospitalization; Human; Incidence; Individual; Industry; Infection; Infection Control; Infrastructure; Institutes; Laboratories; Leadership; Life; Living Standards; Malawi; Meat; Modeling; Molecular; National Institute of Allergy and Infectious Disease; North Carolina; Performance; Pharmacy facility; Planets; Plants; Play; Population; Populations at Risk; Positioning Attribute; Prevention; Prevention strategy; Principal Investigator; Protocols documentation; Public Health; Quarantine; Reporting; Research; Resources; Role; Rural; Senior Scientist; Site; Social Distance; South Korea; Southeastern Asia; Southern Africa; Structure; Taiwan; Tennessee; Testing; Therapeutic; Time; Unemployment; United States National Institutes of Health; Universities; Vaccines; Vietnam; Virus; Work; authority; clinical research site; data management; experience; global health; improved; innovation; microbicide; operation; pandemic disease; preservation; prevent; quality assurance; racial and ethnic disparities; response; rural area; rural counties; screening; transmission process; urban area

Project Summary/Abstract The University of North Carolina (UNC) Global HIV Clinical Trials Unit (CTU) has a well established track record of high-quality, innovative clinical research, strong scientific leadership (both in and outside the NIH HIV/AIDS Networks), and access to critically important infected and at-risk populations in the Southeastern US, Southeast Asia and in Southern Africa. Drawn from a diverse team of clinical innvestigators spanning two continents, our is led by experienced principal investigators (Joseph Eron MD and Mina Hosseinipour MD) and will support all 5 NIH HIV Clinical Trials Networks: Adult Therapeutic Strategies, Strategies to Address HIV and HIV- associated Infections in Pediatric and Maternal Populations, Integrated HIV Prevention Strategies, Microbicide Strategies, and Vaccine Strategies to Prevent HIV Infection. The Clinical Research Sites (CRS) include Chapel Hill CRS led by David Wohl MD (Adult Therapeutic Strategies, Integrated Prevention, Microbicide and Vaccine), Greensboro CRS led by Cornelius Van Dam MD PhD (Adult Therapeutic Strategy and Integrated Prevention), Malawi CRS led by Lameck Chinula MD (all 5 Networks) and Vietnam (protocol specific site) led by Vivian Go. Supporting this leadership is a well-organized research team, comprising global experts and site collaborators who will work to execute the network scientific agendas. The CTU has also assembled a diverse group of senior scientists and public health officials to serve on our Scientific and Strategic Advisory Group. The CTU administration incorporates a highly organized structure that will be responsive to our experienced research teams across the CRS and will provide ongoing evaluation to ensure optimal performance and efficiency. The CTU is supported by state-of-the-art communications and outstanding laboratory, pharmacy, quality assurance, data management and regulatory support. With its robust administrative framework, the UNC Global HIV CTU is optimally positioned to provide scientific leadership and clinical trials infrastructure to advance the field of agenda of the NIAID HIV networks and emerging infectious disease such as the SARS-CoV-2 pandemic.

项目概要/摘要 北卡罗来纳大学 (UNC) 全球艾滋病毒临床试验中心 (CTU) 拥有良好的 建立了高质量、创新的临床研究记录和强大的科学领导力 （NIH HIV/AIDS 网络内外），以及接触极其重要的感染者和艾滋病毒感染者的机会 美国东南部、东南亚和南部非洲的高危人群。取自 我们的团队由横跨两大洲的多元化临床研究人员组成，由经验丰富的领导者领导 首席研究员（Joseph Eron 医学博士和 Mina Hosseinipour 医学博士）并将支持所有 5 名 NIH HIV 临床试验网络：成人治疗策略、解决 HIV 和 HIV- 的策略 儿科和孕产妇相关感染、艾滋病毒综合预防 预防 HIV 感染的策略、杀微生物剂策略和疫苗策略。临床 研究中心 (CRS) 包括由 David Wohl MD（成人治疗中心）领导的 Chapel Hill CRS 策略、综合预防、杀微生物剂和疫苗），格林斯伯勒 CRS，由 Cornelius 领导 Van Dam MD 博士（成人治疗策略和综合预防），马拉维 CRS 领导 Lameck Chinula MD（所有 5 个网络）和 Vivian Go 领导的越南（协议特定站点）。 支持这种领导力的是一个组织良好的研究团队，由全球专家和现场人员组成 将致力于执行网络科学议程的合作者。 CTU 还 召集了一群由资深科学家和公共卫生官员组成的多元化团队，为我们服务 科学和战略咨询小组。 CTU 管理部门高度重视 组织结构将响应我们整个 CRS 经验丰富的研究团队 并将提供持续的评估，以确保最佳的性能和效率。反恐组是 由最先进的通讯和出色的实验室、药房、质量支持 保证、数据管理和监管支持。凭借其健全的管理框架， 北卡罗来纳大学全球 HIV CTU 处于提供科学领导和临床支持的最佳位置 试验基础设施以推进 NIAID HIV 网络和新兴议程领域 传染病，例如 SARS-CoV-2 大流行。